Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan
7 hours ago • Google News
Castle Biosciences Inc (CSTL)
US$ 26.44-0.23%
Price Chart
Key Statistics
Market Cap
$ 567.63M
P/E Ratio
0.00
Revenue (TTM)
$ 347.08M
Volume
243.27K
52W High
$ 35.84
52W Low
$ 15.45
Dividend Yield
0.00%
Beta
1.04
Technicals
50-Day MA
18.0635
200-Day MA
24.5708
52 Week High
35.84
52 Week Low
15.45
About CSTL
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health .
Employees
784
Headquarters
Friendswood, TX
CEO
Mr. Derek J. Maetzold
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg